Can adjuvant chemotherapy improve survival in patients with early-stage, resected non-small-cell lung cancer?

Nature Clinical Practice Oncology

Volumn 2, Issue 11, 2005, Pages 552-553

  Azzoli, Christopher G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Cisplatin; Non small cell lung cancer; Survival; Vinorelbine

Indexed keywords

ANGIOGENESIS INHIBITOR; CARBOPLATIN; CISPLATIN; CORTICOSTEROID; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; ETOPOSIDE; NAVELBINE; ONDANSETRON; PACLITAXEL; VINBLASTINE; VINDESINE;

ANOREXIA; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONSTIPATION; DRUG EFFICACY; DRUG FATALITY; DRUG MEGADOSE; DRUG SAFETY; FATIGUE; FEBRILE NEUTROPENIA; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; NAUSEA; NEUTROPENIA; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZATION; SENSORY NEUROPATHY; SHORT SURVEY; VOMITING;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; CISPLATIN; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASM STAGING; SURVIVAL RATE; VINBLASTINE;

EID: 28444435199     PISSN: 17434254     EISSN: 17434262     Source Type: Journal    
DOI: 10.1038/ncponc0350     Document Type: Short Survey

References (4)

1. Ginsberg RJ and Rubinstein LV (1995) Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 60: 615-622
2. Arriagada R et al. (2004) Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 350: 351-360
3. Douillard JY et al. (2005) ANITA: Phase III adjuvant vinorelbine (N) and cisplatin (P) versus observation (OBS) in completely resected (stage I-III) non-small cell lung cancer (NSCLC) patients (pts): Final results after 70-month median follow-up. On behalf of the Adjuvant Navelbine International Trialist Association. [abstract #7013] J Clin Oncol 23:624s
4. Strauss GM et al. (2004) Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in stage IB non-small cell lung cancer (NSCLC): Report of Cancer and Leukemia Group B (CALGB) Protocol 9633. [abstract #7019] J Clin Oncol 22:621s